R.W. Carrell

985 total citations
25 papers, 794 citations indexed

About

R.W. Carrell is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, R.W. Carrell has authored 25 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 8 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in R.W. Carrell's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Iron Metabolism and Disorders (5 papers) and Hemoglobinopathies and Related Disorders (5 papers). R.W. Carrell is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Iron Metabolism and Disorders (5 papers) and Hemoglobinopathies and Related Disorders (5 papers). R.W. Carrell collaborates with scholars based in United Kingdom, New Zealand and United States. R.W. Carrell's co-authors include H. Lehmann, David J. Perry, H. Lehmann, Paul Harper, Maurice C. Owen, James Travis, P.M. George, Steven Rosenberg, Robert W. Colman and Cheryl F. Scott and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.

In The Last Decade

R.W. Carrell

25 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R.W. Carrell United Kingdom	16	357	271	261	203	112	25	794
T Suyama Japan	12	315 0.9×	169 0.6×	174 0.7×	309 1.5×	44 0.4×	27	724
Seldon E. Bernstein United States	14	220 0.6×	198 0.7×	197 0.8×	23 0.1×	65 0.6×	25	728
Michael Bromberg United States	17	438 1.2×	275 1.0×	206 0.8×	159 0.8×	29 0.3×	27	930
Motoi Sugimura Japan	18	193 0.5×	245 0.9×	61 0.2×	298 1.5×	71 0.6×	53	929
Johannes C. Kirchheimer Austria	21	484 1.4×	286 1.1×	113 0.4×	815 4.0×	43 0.4×	41	1.2k
Timothy J. Ernst United States	7	188 0.5×	494 1.8×	152 0.6×	57 0.3×	123 1.1×	8	955
Bertil Lindmark Sweden	14	110 0.3×	153 0.6×	50 0.2×	100 0.5×	42 0.4×	50	609
ME Nesheim United States	13	1.1k 3.1×	215 0.8×	351 1.3×	174 0.9×	68 0.6×	19	1.4k
Sheila N.J. Sait United States	20	511 1.4×	510 1.9×	206 0.8×	192 0.9×	47 0.4×	72	1.2k
Eijiro Omoto Japan	14	900 2.5×	535 2.0×	311 1.2×	79 0.4×	28 0.3×	45	1.3k

Countries citing papers authored by R.W. Carrell

Since Specialization

Citations

This map shows the geographic impact of R.W. Carrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.W. Carrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.W. Carrell more than expected).

Fields of papers citing papers by R.W. Carrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.W. Carrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.W. Carrell. The network helps show where R.W. Carrell may publish in the future.

Co-authorship network of co-authors of R.W. Carrell

This figure shows the co-authorship network connecting the top 25 collaborators of R.W. Carrell. A scholar is included among the top collaborators of R.W. Carrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.W. Carrell. R.W. Carrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daly, Mary E., Robert C. Tait, Isobel D. Walker, et al.. (1998). Antithrombin Cambridge II (Ala384Ser): Clinical, Functional and Haplotype Analysis of 18 Families. Thrombosis and Haemostasis. 79(2). 249–253. 17 indexed citations

Harper, Paul, G. R. Park, & R.W. Carrell. (1996). The plasma turnover of transfused antithrombin concentrate in patients with acquired antithrombin deficiency. Transfusion Medicine. 6(1). 45–50. 4 indexed citations

Marshall, C. J., J.Y. Borg, Robert C. Tait, et al.. (1995). Two novel antithrombin variants, Asn187Asp and Asn187Lys, indicate a functional role for asparagine 187. Blood Coagulation & Fibrinolysis. 6(1). 51–54. 8 indexed citations

Perry, David J. & R.W. Carrell. (1992). Hydrolink gels: a rapid and simple approach to the detection of DNA mutations in thromboembolic disease.. Journal of Clinical Pathology. 45(2). 158–160. 29 indexed citations

Harper, Paul, et al.. (1991). A pilot study of antithrombin replacement in intensive care management: the effects on mortality, coagulation and renal function. Transfusion Medicine. 1(2). 121–128. 9 indexed citations

Harper, Paul, Mary E. Daly, John C. Price, P F Edgar, & R.W. Carrell. (1991). Screening for heparin binding variants of antithrombin.. Journal of Clinical Pathology. 44(6). 477–479. 21 indexed citations

Perry, David J., et al.. (1989). Antithrombin Cambridge, 384 Ala to Pro: A new variant identified using the polymerase chain reaction. FEBS Letters. 254(1-2). 174–176. 53 indexed citations

Owen, Maurice C., G. John Shaw, E Grau, et al.. (1989). Molecular characterization of antithrombin barcelona-2: 47 arginine to cysteine. Thrombosis Research. 55(4). 451–457. 6 indexed citations

Harper, Paul, R. Luddington, Ian Jennings, et al.. (1989). Coagulation changes following hepatic revascularization during liver transplantation.. PubMed. 48(4). 603–7. 38 indexed citations

10.

Harper, Paul, R. Luddington, R.W. Carrell, et al.. (1988). PROTEIN C DEFICIENCY AND PORTAL THROMBOSIS IN LIVER TRANSPLANTATION IN CHILDREN. The Lancet. 332(8617). 924–927. 53 indexed citations

11.

Aulak, Kulwant S., Philip A. Pemberton, Fred S. Rosen, et al.. (1988). Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 ‘reactive centre’ (Arg444→His) mutation. Biochemical Journal. 253(2). 615–618. 56 indexed citations

12.

Scott, Cheryl F., R.W. Carrell, Charles B. Glaser, et al.. (1986). Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.. Journal of Clinical Investigation. 77(2). 631–634. 83 indexed citations

13.

Travis, James, et al.. (1985). Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor.. Journal of Biological Chemistry. 260(7). 4384–4389. 121 indexed citations

14.

Bathurst, Ian, et al.. (1985). Human Z α₁‐antitrypsin accumulates intracellularly and stimulates lysosomal activity when synthesised in the Xenopus oocyte. FEBS Letters. 183(2). 304–308. 20 indexed citations

15.

Riley, J., Ian Bathurst, Mark R. Edbrooke, R.W. Carrell, & R K Craig. (1985). α₁‐Antitrypsin and serum albumin mRNA accumulation in normal, acute phase and ZZ human liver. FEBS Letters. 189(2). 361–366. 7 indexed citations

16.

Wilkinson, Tim, Peter J. Gough, Maurice C. Owen, R.W. Carrell, & Henry M. Kronenberg. (1975). THE ISOLATION AND IDENTIFICATION OF HAEMOGLOBIN LEPORE BOSTON (WASHINGTON) IN AN AUSTRALIAN FAMILY. The Medical Journal of Australia. 2(18). 706–709. 4 indexed citations

17.

Gough, Peter J., et al.. (1974). DETECTION OF VARIANTS OF HAEMOGLOBIN D IN AUSTRALIA: HAEMOGLOBIN D CAMPERDOWN a ₂ ^A β ₂ ^{121 Glu → Val} AND HAEMOGLOBIN D PUNJAB a ₂ ^A β ₂. The Medical Journal of Australia. 2(17). 636–637. 10 indexed citations

18.

Carrell, R.W., et al.. (1971). The Significance of Monoclonal Gammopathy in a Normal Population*. Australian and New Zealand Journal of Medicine. 1(4). 398–401. 17 indexed citations

19.

Carrell, R.W. & H. Lehmann. (1969). The unstable haemoglobin haemolytic anaemias.. PubMed. 6(2). 116–32. 65 indexed citations

20.

Lehmann, H. & R.W. Carrell. (1968). Differences between - and -Chain Mutants of Human Haemoglobin and between - and -Thalassaemia. Possible Duplication of the -Chain Gene. BMJ. 4(5633). 748–750. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact